Floatz logo

Therapeutic Asset Ratings

409 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
HUMAN PERIPHERAL BLOOD LEUKOCYTES
Ovarian Cancer
A2 Biotherapeutics Inc.D (26)
NKG2D CAR-NK
Ovarian Cancer
Hangzhou Cheetah Cell Therapeutics Co., LtdN/AD (26)
PAN-FGFR TYROSINE KINASE INHIBITOR JNJ-42756493
Ovarian Cancer
University Health Network, TorontoN/AD (26)
Pregabalin
Ovarian Cancer
Zhejiang Cancer HospitalN/AD (26)
S-Ketamine
Ovarian Cancer
Zhejiang Cancer HospitalN/AD (26)
sy001
Ovarian Cancer
Cell Origin Biotech (Hangzhou) Co., Ltd.N/AD (26)
ft538
Ovarian Cancer
Masonic Cancer Center, University of MinnesotaP1D (24)
Ckd-215
Ovarian Cancer
Chong Kun Dang PharmaceuticalP1NR (0)
d215
Ovarian Cancer
Chong Kun Dang PharmaceuticalP1NR (0)
Showing 401 to 409 of 409 assets
PreviousPage 17 of 17Next